Shengnan Du
About Shengnan Du
Shengnan Du is a Sr. Research Investigator at Bristol Myers Squibb with extensive experience in cancer research and pharmacometrics.
Title
Shengnan Du holds the title of Senior Research Investigator.
Company
Shengnan Du is currently employed at Bristol Myers Squibb, located in New Jersey, United States, as a Senior Research Investigator.
Education and Expertise
Shengnan Du achieved a Master of Science (MS) in Pharmacometrics from the University of Maryland, Baltimore (UMB), graduating between 2019 and 2021. She also holds a Doctor of Philosophy (Ph.D.) in Biomedical Science and Cancer Biology from The University of Toledo, completing this program from 2012 to 2017. Additionally, she obtained a Master of Science (MS) in Pharmacology from China Pharmaceutical University, which she attended from 2009 to 2012.
Background
Shengnan Du has a rich professional background that includes a stint at the FDA as an ORISE fellow from 2020 to 2021. Before that, she served as a Postdoctoral Researcher at the National Human Genome Research Institute (NHGRI) from 2018 to 2020. Her early career included working as a Researcher and Ph.D. Student at The University of Toledo from 2012 to 2017, located in Toledo, Ohio.
Achievements
Shengnan Du has developed an algorithm for sensitive dose selection using modeling and simulation approaches in TMDD-driven PK under biosimilar development settings. She also investigated the impact of anatomical injection sites and devices on the pharmacokinetics and bioavailability of 10 FDA-approved monoclonal antibodies and Fc fusion proteins. Furthermore, she has over 7 years of research experience focusing on the discovery and investigation of novel small molecules as anti-cancer drugs.